A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome (Q39692110)
Jump to navigation
Jump to search
scientific article published on 13 August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome |
scientific article published on 13 August 2004 |
Statements
1 reference
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome (English)
1 reference
Yukiho Tanimoto
1 reference
Masahiko Yokozeki
1 reference
Kenji Hiura
1 reference
Kazuya Matsumoto
1 reference
Hideki Nakanishi
1 reference
Toshio Matsumoto
1 reference
Pierre J Marie
1 reference
Keiji Moriyama
1 reference
13 August 2004
1 reference
1 reference
279
1 reference
44
1 reference
45926-45934
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference